Status:
COMPLETED
Clinical Response and Safety Following FMT for UC
Lead Sponsor:
Air Force Military Medical University, China
Conditions:
Inflammatory Bowel Diseases
Fecal Microbiota Transplantation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The study aims to evaluate the clinical efficacy and safety of fecal microbiota transplantation by automatic methods in the treatment of moderate to severe active ulcerative colitis. There are two gro...
Eligibility Criteria
Inclusion
- \- Eligible patients required a diagnosis of ulcerative colitis made by a primary gastroenterologist based upon history, physical exam, laboratory/radiological studies and gastrointestinal histology. All patients were age ≥ 18 year old at the time of enrollment. They had moderate to severe symptoms with a mayo score between 6\~12 and an endoscopic subscore ≥2. Patient medication for UC could not have changed for at least one month prior to FMT.
Exclusion
- \- Active or history of intraabdominal abscess, acute abdomen or other clinical emergencies requiring emergent management, pregnancy, prior history of FMT, prior history of TNF inhibitors use, or other serious systemic disease.
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2018
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04294615
Start Date
April 1 2016
End Date
March 31 2018
Last Update
March 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.